Macrokine (WF10): Completed Phase III trial enrollment

WF10 also is in Phase II testing to treat chronic hepatitis C infection (see BioCentury, July 10). The product is marketed in Thailand under the name Immunokine to treat cystitis, proctitis and mucosi...